What is the correct term for blood flow through the lung?

A. Metered-dose inhaler (MDI): MDIs deliver a specific dose of medication in aerosol form. They consist of a pressurized canister containing medication and a mouthpiece or mask for inhalation. Patients must coordinate inhalation with actuation to ensure proper medication delivery to the lungs.

B. Nebulizer: Nebulizers convert liquid medication into a fine mist that can be inhaled directly into the lungs. They are commonly used for patients who have difficulty using MDIs or require higher doses of medication. Nebulizers are often used in acute care settings or at home for patients with chronic respiratory conditions.

C. Hypodermic syringe: Hypodermic syringes are used for administering injections subcutaneously, intramuscularly, or intravenously. They are not used for inhalation medication administration.

D. Feeding tube syringe: Feeding tube syringes are used for administering liquid medications or enteral feeds through feeding tubes directly into the gastrointestinal tract. They are not used for inhalation medication administration.

E. Dry powder inhaler (DPI): DPIs deliver medication in powdered form, which is activated by the patient's inhalation. Unlike MDIs, DPIs do not require coordination between actuation and inhalation. Instead, patients inhale forcefully to disperse the medication into their lungs.

A) H2-receptor blockers:
H2-receptor blockers, such as ranitidine and famotidine, are commonly used to reduce stomach acid production and treat peptic ulcer disease. They help promote ulcer healing and alleviate symptoms. These medications are generally safe and appropriate for use in clients with peptic ulcer disease.

B) Antacids:
Antacids are medications that neutralize stomach acid and provide symptomatic relief from peptic ulcer disease. While they do not directly treat the underlying cause of the ulcer, they can help alleviate symptoms such as pain and discomfort. Antacids are generally safe for use in clients with peptic ulcer disease.

C) PPIs (Proton Pump Inhibitors):
PPIs, such as omeprazole and pantoprazole, are potent acid-suppressing medications commonly used to treat peptic ulcer disease and gastroesophageal reflux disease (GERD). They are effective at reducing stomach acid production and promoting ulcer healing. PPIs are generally safe and appropriate for use in clients with peptic ulcer disease.

D) NSAIDs (Nonsteroidal Anti-Inflammatory Drugs).
NSAIDs, such as ibuprofen, aspirin, and naproxen, can exacerbate peptic ulcer disease by increasing the risk of gastric irritation, erosion, and ulceration. These medications inhibit the production of prostaglandins, which help protect the stomach lining. Chronic or excessive use of NSAIDs can lead to the development of new ulcers or worsening of existing ulcers. Therefore, clients with peptic ulcer disease are typically advised to avoid NSAIDs or to use them with caution under the guidance of a healthcare provider.